And the nation’s leading organization of infectious-disease doctors recommends against using ivermectin outside of clinical trials. He opposes waiting for data from large randomized clinical trials to authorize its use, saying too many people are dying of covid-19. Interest in ivermectin for covid-19 surged last spring after a small Australian study found that the drug inhibited the replication of the coronavirus in laboratory tests. That was a month before the first big clinical trial — the British Recovery trial — showed the value of the steroid dexamethasone. Last August, the NIH committee that issues covid-19 treatment guidelines recommended against the use of ivermectin outside of clinical trials.

Source: Washington Post April 08, 2021 12:01 UTC